NEW YORK, Sept. 13 (GenomeWeb News) - Qiagen said today that it has signed a deal to combine its TOM-amidites chemistry-based RNAi products with Evotec Technologies' imaging Opera platform.
To read the full story....
Already have a GenomeWeb or 360Dx account?
.